T73375 |
CK2-IN-4
|
313985-59-0
|
99.75%
|
|
CK2-IN-4 is a protein kinase (CK2) inhibitor with an IC50 value of 8.6 µM. CK2-IN-4 has potential anticancer ah and anti-inflammatory activity for the study of v...
|
T5358 |
Longdaysin
|
1353867-91-0
|
99.74%
|
|
Longdaysin is an inhibitor of CK1α and CK1δ (IC50s: 5.6/8.8 µM). It also can inhibit ERK2 (IC50: 52 µM).
|
T6150 |
TAK-715
|
303162-79-0
|
99.69%
|
|
TAK-715 is a p38 MAPK inhibitor for p38α.
|
T9356 |
(E/Z)-GO289
|
694522-87-7
|
99.68%
|
|
(E/Z)-GO289, which strongly lengthened circadian period, is a potent and selective inhibitor of CK2. (E/Z)-GO289 exhibited cell type-dependent inhibition of canc...
|
T77709 |
Casein kinase 1δ-IN-8
|
851396-73-1
|
99.66%
|
|
Casein kinase 1δ-IN-8 is an inhibitor of casein kinase 1δ and is used to treat neurodegenerative diseases such as Alzheimer's disease type.
|
T2048 |
LY-364947
|
396129-53-6
|
99.65%
|
|
LY-364947 (HTS466284) is a potent ATP-competitive inhibitor of TGFβR-I.
|
T7390 |
DMAT
|
749234-11-5
|
99.58%
|
|
DMAT (Casein kinase II Inhibitor) is a potent and specific inhibitor of CK2(IC50 value of 130 nM).
|
T15024 |
Silmitasertib sodium salt
|
1309357-15-0
|
99.49%
|
|
Silmitasertib sodium salt (CX-4945 sodium salt) is a potent and orally bioavailable, highly selective inhibitor of CK2(IC50 of 1 nM, CK2α).
|
T2259 |
Silmitasertib
|
1009820-21-6
|
99.47%
|
|
Silmitasertib (CX-4945) is a potent, orally bioavailable inhibitor of casein kinase 2 (CK2; Ki: 0.38 nM).
|
T60295 |
Casein kinase 1δ-IN-1
|
851871-94-8
|
99.46%
|
|
Casein kinase 1δ-IN-1 (WAY-643895) is an inhibitor of casein kinase 1δ (CK1δ), which inhibits CK1δ. Casein kinase 1δ-IN-1 can be used in the study of neurodegene...
|
T2695 |
TBB
|
17374-26-4
|
99.45%
|
|
TBB (NSC-231634)(NSC-231634) is a highly selective, ATP/GTP-competitive inhibitor of casein kinase-2 (CK2).
|
T60067 |
WAY-297174
|
442571-27-9
|
99.43%
|
|
WAY-297174 is a human protein kinase CK2 inhibitor with IC50 of > 33 μM.
|
T3073 |
PF-670462
|
950912-80-8
|
99.42%
|
|
PF-670462 is a potent (IC50 = 7.7 ± 2.2 nM) and selective (>30-fold with respect to 42 additional kinases) inhibitor of CK1ε in isolated enzyme preparations.
|
T64350 |
Casein kinase 1δ-IN-3
|
349438-77-3
|
99.42%
|
|
Casein kinase 1δ-IN-3 (Casein kinase 1δ-IN-3) (Compound 23a) is a casein kinase 1 delta (CK1d) inhibitor with a pIC50 of 6.5376 M.
|
T71339 |
BMS-863233 HCl
|
1169562-71-3
|
99.42%
|
|
BMS-863233 HCl is an ATP-competitive Cdc7 inhibitor (IC50: 3.4 nM) that is potent and selective.BMS-863233 HCl inhibited CK2 and PIM1 with IC50 values of 215 and...
|
T16528 |
PI-828
|
942289-87-4
|
99.39%
|
|
PI-828 is a phosphatidylinositol 3-kinase (PI3K) inhibitor, which is widely used to study the physiological function of PI3K and also promotes stem cell differen...
|
T3352 |
XL413
|
1169558-38-6
|
99.38%
|
|
XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. XL-413 binds to and inhibits the a...
|
T60608 |
FPFT-2216
|
2367619-87-0
|
99.35%
|
|
FPFT-2216 is a "molecular glue" compound that degrades IKZF6, IKZF1, DE1D, and CK3α. FPFT-2216 has potential antitumor activity and can be used to study immune s...
|
T21915 |
TBCA
|
934358-00-6
|
99.31%
|
|
TBCA (Casein Kinase II Inhibitor III, TBCA) is a highly selective CK2 (casein kinase II) inhibitor, IC50 = 110 nM, Ki = 77 nM. TBCA shows selectivity for CK2 ove...
|
T6208 |
AS-252424
|
900515-16-4
|
99.26%
|
|
AS-252424 is a potent and selective inhibitor of PI3Kγ with IC50 of 33 nM; >10 fold selectivity for PI3Kγ versus PI3Kα.
|